Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged between 18 â?? 80 years undergoing elective cases of hip fracture surgeries like intertrochanteric, subtrochanteric , total hip replacement and hip arthroplasties. 2. Patients willing to give written informed consent[annexure 1(a)] 3. Patients belonging to ASA I and II[annexure 3(a)]
Exclusion criteria
Exclusion criteria: 1. Patients with coagulopathy 2. Patients with infection at the injection site 3. Patients with allergy to local anesthetics 4. Patients with severe cardiopulmonary disease (>=ASA IV) 5. Patients who are diabetic or other neuropathies 6. Patients receiving opioids for chronic analgesic therapy 7. Patients with contraindication to spinal anesthesia 8. Patients who are unable to comprehend visual analog scale (VAS)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in pain (VAS) score following the block Prolongation of sensory blockade Time for sensory regression Total duration of sensory blockade Total duration of analgesia will be noted Timepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Post operative pain will be assessed using visual analogue scale (0-10) which will be followed by Pericapsular nerve group block or Fascia iliaca block and visual analogue score will be reassessed Visual analogue scores for pain recorded immediate post subarachnoid blockade, then 2nd hourly for first 6 hours, and at 12 and 24 hours post operatively. Analgesic requirement for first 24 hours post operatively. Adverse effects if any Timepoint: 12 weeks | — |
Countries
India
Contacts
Bangalore Medical College and Research Institute